Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Medical Grand Rounds

  • You have access
    Radiofrequency ablation of the pulmonary veins: Can it stop atrial fibrillation at its source?
    Andrea Natale, MD
    Cleveland Clinic Journal of Medicine January 2001, 68 (1) 17-23;

    Atrial fibrillation appears to originate in the pulmonary veins; ablation could be a cure.

  • You have access
    Andropause, testosterone therapy, and quality of life in aging men
    John E. Morley, MB, BCh
    Cleveland Clinic Journal of Medicine December 2000, 67 (12) 880-882;

    The common wisdom that men do not undergo menopause is being replaced. Testosterone replacement therapy can help.

  • You have access
    In diabetes, treat hidden heart disease
    Willa A. Hsueh, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 807-813;

    Both diabetic and prediabetic patients have abnormal vascular reactivity and should be considered to have occult cardiovascular disease.

  • You have access
    Heart failure is a fever: The cytokine connection
    James B. Young, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 801-803;

    The discovery that inflammation contributes to heart failure may lead to new therapies for this disease.

  • You have access
    Osteoporosis: Which current treatments reduce fracture risk?
    Daniel T. Baram, MD
    Cleveland Clinic Journal of Medicine October 2000, 67 (10) 701-703;

    With effective agents available, physicians should make osteoporosis treatment a priority, especially for patients at high risk.

  • You have access
    Heparin-induced thrombocytopenia: How to manage it, how to avoid it
    Enrico Caiola, MD
    Cleveland Clinic Journal of Medicine September 2000, 67 (9) 621-624;

    What to do when heparin paradoxically causes the very problem it is given to prevent.

  • You have access
    Palliative medicine: Old dogs and new tricks
    Mellar P. Davis, MD
    Cleveland Clinic Journal of Medicine August 2000, 67 (8) 557-559;

    Some older drugs can be used for off-label indications, to either substitute for or augment the palliative action of approved drugs.

  • You have access
    Maximizing antihypertensive management in the elderly
    Norman Kaplan, MD
    Cleveland Clinic Journal of Medicine August 2000, 67 (8) 551-553;

    A checklist of specific considerations when treating hypertension in the elderly.

  • You have access
    Treatment strategies for hepatitis C: Making the best of limited options
    John G. McHutchison, MD and Zobair Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine July 2000, 67 (7) 476-480;

    With interferon and ribavirin therapy, 40% of patients with hepatitis C can be cured. Determining the genotype of the virus can help guide therapy.

  • You have access
    Controversies in the diagnosis and treatment of gestational diabetes
    Lois Jovanovic, MD
    Cleveland Clinic Journal of Medicine July 2000, 67 (7) 481-488;

    Despite agreement about the dangers of gestational diabetes to mother and child, many practical questions remain about how best to detect and treat it.

Pages

  • Previous
  • Next
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 23

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire